Literature DB >> 10879591

C-reactive protein and serum amyloid A protein in neonatal infections.

C Pizzini1, M Mussap, M Plebani, V Fanos.   

Abstract

In this study, we examine C-reactive protein (CRP) and serum amyloid protein A (SAA). Although the former is the best known and most commonly used indicator of inflammation, certain considerations underline the inadequacy of CRP determination alone for the early diagnosis of infection. In fact symptoms often precede the CRP elevation. SAA protein comprises a family of polymorphic apolipoproteins produced mainly by the liver, and several studies have stressed its importance in the diagnosis and monitoring of various diseases. Pathological SAA values are often detected in association with normal CRP concentrations. SAA rises earlier and more sharply than CRP. Finally, contrary to CRP, SAA presents the same trend in viral as well as bacterial infections. Although the data available on SAA in neonates are currently very limited, it is possible to postulate a role of primary importance for SAA in the management of neonatal infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10879591     DOI: 10.1080/00365540050165848

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  11 in total

1.  Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization.

Authors:  Sheng-Wei Ren; Xia Qi; Chang-Kai Jia; Yi-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

2.  Development of quantitative mass spectrometric immunoassay for serum amyloid A.

Authors:  Olgica Trenchevska; Hussein N Yassine; Chad R Borges; Randall W Nelson; Dobrin Nedelkov
Journal:  Biomarkers       Date:  2016-07-22       Impact factor: 2.658

3.  Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs.

Authors:  Michelle B Christensen; Rebecca Langhorn; Amelia Goddard; Eva B Andreasen; Elena Moldal; Asta Tvarijonaviciute; Jolle Kirpensteijn; Sabrina Jakobsen; Frida Persson; Mads Kjelgaard-Hansen
Journal:  Can Vet J       Date:  2014-02       Impact factor: 1.008

4.  Factors which affect mortality in neonatal sepsis.

Authors:  Esma Ebru Turhan; Tuğba Gürsoy; Fahri Ovalı
Journal:  Turk Pediatri Ars       Date:  2015-09-01

5.  Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 during and after delivery.

Authors:  Luciane Marzzullo Cicarelli; Adriana Guimarães Perroni; Marcelo Zugaib; Paulo Basto de Albuquerque; Ana Campa
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

Review 6.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

7.  Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children.

Authors:  Inge M L Ahout; Kim H Brand; Aldert Zomer; Wilhelma H van den Hurk; Geurt Schilders; Marianne L Brouwer; Chris Neeleman; Ronald de Groot; Gerben Ferwerda
Journal:  BMJ Open       Date:  2017-06-30       Impact factor: 2.692

8.  Comparison of C-reactive protein and serum amyloid a protein in septic shock patients.

Authors:  Domingos Dias Cicarelli; Joaquim Edson Vieira; Fábio Ely Martins Benseñor
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

9.  Serum amyloid A, procalcitonin, tumor necrosis factor-alpha, and interleukin-1beta levels in neonatal late-onset sepsis.

Authors:  Birsen Ucar; Bilal Yildiz; M Arif Aksit; Coskun Yarar; Omer Colak; Yildiz Akbay; Ertugrul Colak
Journal:  Mediators Inflamm       Date:  2008-11-16       Impact factor: 4.711

10.  Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis.

Authors:  Haining Yuan; Jie Huang; Bokun Lv; Wenying Yan; Guang Hu; Jian Wang; Bairong Shen
Journal:  Biomed Res Int       Date:  2013-08-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.